Camad, Nadzman .
HRN: 21-88-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2025
CEFUROXIME 1.5GM (VIAL)
10/04/2025
10/05/2025
IVT
1.5GMS
Q8
LTCS
Waiting Final Action
10/04/2025
CEFUROXIME 500MG (TAB)
10/06/2025
10/13/2025
PO
500 MG
BID
NKA
Waiting Final Action